U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07497503) titled 'A Study of B-3E07 and Forsteo(R) in Healthy Adult Female Participants' on March 23.

Brief Summary: The main aim of the study is to evaluate the pharmacokinetic (PK) biosimilarity of B-3E07 and European Union (EU) - sourced Forsteo(R) in healthy adult female participants.

Study Start Date: April 10

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: BIOLOGICAL: Forsteo(R)

Forsteo(R) will be administered as SC injection.

BIOLOGICAL: B-3E07

B-3E07 will be administered as SC injection.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Syneos Health

Disclaimer: Curated by HT Syndication....